Adcendo vs ME Therapeutics Holdings

Adcendo vs ME Therapeutics Holdings, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adcendo is on 60/100 and ME Therapeutics Holdings on 28/100.

Adcendo logo
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Try Adcendo
ME Therapeutics HoldingsBiotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer.
Try ME Therapeutics Holdings

Where each one leads

Adcendo

  • our overall score: 60/100 against 28/100
  • funding raised: $272M against $500K

ME Therapeutics Holdings

Leads on none of the measures we hold for both companies.

At a glance

MeasureAdcendoME Therapeutics Holdings
What it isDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.Biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer.
CategoryBiotechnology, Pharmaceuticals, Oncology, Drug DiscoveryBiotechnology, Healthcare, Pharmaceuticals, Cancer Research
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20172017
HeadquartersCopenhagen, DenmarkVancouver, Canada
StatusActiveInactive

Size, funding and growth

MeasureAdcendoME Therapeutics Holdings
Employees60Not published
Total funding$272M$500K
Latest roundSeries CPrivate Placement
LinkedIn followers9,847Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdcendoME Therapeutics Holdings
StartupHub scoreOur 0-100 rating60/10028/100
Traction58/10028/100
Team70/100Not published
CommunityNot published14/100
Search visibility34/10017/100
Quality68/10035/100
Agent readinessHow well an AI agent can read and act on the siteF (33/100)Not published
Domain ratingLink authority, 0-10028/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdcendoME Therapeutics Holdings
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksJqueryNot detected
AnalyticsGoogle Analytics 4Not detected

Adcendo vs ME Therapeutics Holdings: common questions

Which is better, Adcendo or ME Therapeutics Holdings?

On our 0-100 score Adcendo rates higher (60/100 against 28/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.

How do Adcendo and ME Therapeutics Holdings compare on the numbers?

Adcendo leads on our overall score (60/100 against 28/100), funding raised ($272M against $500K).

Read the full Adcendo review and pricing or the ME Therapeutics Holdings review and pricing. You can also browse other Adcendo alternatives we track.